AIM2 and gastrointestinal disease: Importantly, considering these complexities regarding AIM2 biological functions in gastrointestinal pathologies, future studies are warranted to couple conditional knockout strains of AIM2 with gastrointestinal disease models (including Helicobacter infection) to identify specific AIM2‐expressing cell types that modulate disease pathogenesis.